[SLN] YoY Quarter Result on 31-Dec-2014 [#Q4]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
30-Dec-2014
Financial Year
2014
Quarter
31-Dec-2014 [#Q4]
Profit Trend
QoQ- 0.00%
YoY- 2.36%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 0 0 385 0 4 38 63 -
PBT -5,370 1,441 -2,410 -2,644 -3,178 -2,798 -1,379 25.41%
Tax 507 508 557 1,392 446 0 0 -
NP -4,862 1,949 -1,854 -1,252 -2,732 -2,798 -1,379 23.35%
Tax Rate - -35.30% - - - - - -
Total Cost 4,862 -1,949 2,239 1,252 2,736 2,836 1,442 22.44%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin 0.00 0.00 -481.43 0.00 -68,300.00 -7,363.16 -2,188.89 -
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS -0.21 0.08 -0.08 -0.05 -0.16 -0.18 -0.15 5.76%
EPS Diluted -0.21 0.08 -0.08 -0.05 -0.16 -0.18 -0.15 5.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.